参考文献/References:
[1] Lee RC，Feinbaum RL，Ambros V. The C. elegans hetero-
chronic gene lin-4encodes small RNAs with antisense
complementarity to lin-14 [J]. Cell, 1993, 75（5）: 843-854.
[2] Zhang J, Guo H, Qian G, et al. miR-145, a new regulator of
the DNA fragmentation factor-45 (DFF45)-mediated apop-
totic network [J]. Mol Cancer, 2010, 9: 211.
[3] Zampetaki A, Willeit P, Drozdov I, et al. Profiling of circula-
ting microRNAs: from single biomarkers to re-wired net-
works [J]. Cardiovasc Res, 2012, 93(4): 555-562.
[4] Hergenreider E, Heydt S, Treguer K, et al. Atheroprotective
communication between endothelial cells and smooth
muscle cells through miRNAs [J]. Nat Cell Biol, 2012, 14
(3): 249-256.
[5] Polimeni A, De Rosa S, Indolfi C. Vascular miRNAs after
balloon angioplasty [J]. Trends Cardiovasc Med, 2013, 23
(1): 9-14.
[6] Kuwabara Y, Ono K, Horie T, et al. Increased microRNA-1
and microRNA-133a levels in serum of patients with car-
diovascular disease indicate the existence of myocardial
damage [J]. Circ Cardiovasc Genet, 2011, 4(4): 446-454.
[7] Silva J, García V, Zaballos á, et al. Vesicle-related micro-
RNAs in plasma of nonsmall cell lung cancer patients and
correlation with survival [J]. Eur Respir J, 2011, 37(3):
617-623.
[8] Bottoni A, Zatelli MC, Ferracin M, et al. Identification of
differentially expressed microRNAs by microarray: a poss-
ible role for microRNA genes in pituitary adenomas [J]. J
Cell Physiol, 2007, 210(2): 370-377.
[9] Stilling G, Sun Z, Zhang S, et al. MicroRNA expression in
ACTH-producing pituitary tumors: up-regulation of micro-
RNA-122 and -493 in pituitary carcinomas [J]. Endocrine,
2010, 38(1): 67-75.
[10] Qian ZR, Asa SL, Siomi H, et al. Overexpression of HMGA2
relates to reduction of the let-7 and its relationship to clini-
copathological features in pituitary adenomas [J]. Mod Pa-
thol, 2009, 22(3): 431-441.
[11] Palumbo T, Faucz FR, Azevedo M, et al. Functional screen
analysis reveals miR-26b and miR-128 as central regula-
tors of pituitary somatomammotmphic tumor growth through
activation of the PTEN-AKT pathway [J]. Oncogene, 2013,
32(13): 1651-1659．
[12] Gentilin E, Tagliati F, Filieri C, et al. miR-26a plays an
important role in cell cycle regulation in ACTH-secreting
pituitary adenomas by modulating protein kinase Cδ [J].
Endocrinology, 2013, 154(5): 1690-1700.
[13] Trivellin G, Butz H, Delhove J. MicroRNA miR-107 is
overexpressed in pituitary adenomas and inhibits the
expression of aryl hydrocarbon receptor-interacting protein
in vitro [J]. Am J Physiol Endocrinol Metab, 2012, 303(6):
E708-E719．
[14] Chen PS, Su JL, Cha ST, et al. miR-107 promotes tumor
progression by targeting the let-7 microRNA in mice and
humans [J]. J Clin Invest, 2011, 121(9): 3442-3455.
[15] Butz H, Likó I, Czirják S, et al. MicroRNA profile indicates
downregulation of the TGFβ pathway in sporadic non-
functioning pituitary adenomas [J]. Pituitary, 2011, 14(2):
112-124.
[16] Mao ZG, He DS, Zhou J, et al. Differential expression of
microRNAs in GH-secreting pituitary adenomas [J]. Diagn
Pathol, 2010, 5: 79.
[17] D'Angelo D, Palmieri D, Mussnich P, et al. Altered micro-
RNA expression profile in human pituitary GH adenomas:
down-regulation of miRNA targeting HMGA1, HMGA2,
and E2F1 [J]. J Clin Endocrinol Metab, 2012, 97(7): 1128-
1138.
[18] Hu X, Zhang P, Shang A, et al. A primary proteomic analy-
sis of serum from patients with nonfunctioning pituitary
adenoma [J]. J Int Med Res, 2012, 40(1): 95-104.
[19] Zhou KY, Jin HH, Bai ZQ, et al. Pituitary adenoma biomar-
kers identified using proteomic fingerprint technology [J].
Asian Pac J Cancer Prev, 2012, 13(8): 4093-4095.
[20] Neidert MC, Sze L, Zwimpfer C, et al. Soluble a-klotho: a
novel serum biomarker for the activity of GH-producing
pituitary adenomas [J]. Eur J Endocrinol, 2013, 168(4):
575-583.
相似文献/References:
[1]苏 里 赵志军 梅小龙 杨建华 包文平 张春阳.调控人骨桥蛋白的miRNA预测研究[J].中国临床神经外科杂志,2016,(04):210.[doi:10.13798/j.issn.1009-153X.2016.04.006]
SU Li,ZHAO Zhi-jun,MEI Xiao-lun,et al.Study of the prediction of microRNA regulating human osteopontin[J].,2016,(06):210.[doi:10.13798/j.issn.1009-153X.2016.04.006]
[2]彭泽生 田道锋 张申起 陈谦学.miR-370-3p对胶质母细胞瘤U87-MG细胞株增殖能力的影响[J].中国临床神经外科杂志,2016,(04):223.[doi:10.13798/j.issn.1009-153X.2016.04.010]
PENG Ze-sheng,TIAN Dao-feng,ZHANG Shen-qi,et al.Effects of MircoRNA-370-3p on proliferation of glioma cell line U87-MG and its potential mechanism[J].,2016,(06):223.[doi:10.13798/j.issn.1009-153X.2016.04.010]
[3]田 其 综述 李明昌 审校.外泌体微小RNA在中枢神经系统疾病诊断中作用的研究进展[J].中国临床神经外科杂志,2019,(09):570.[doi:10.13798/j.issn.1009-153X.2019.09.022]
[4]顾 浩、冯东福.重型颅脑损伤病人外周血miRNA生物信息学分析[J].中国临床神经外科杂志,2019,(12):749.[doi:10.13798/j.issn.1009-153X.2019.12.010]
GU Hao,FENG Dong-fu..Bioinformatics study of microRNA in peripheral blood in patients with severe traumatic brain injury[J].,2019,(06):749.[doi:10.13798/j.issn.1009-153X.2019.12.010]
[5]杨宇浩,李照建,李卓群,等.垂体Rathke囊肿蛋白小体的影像学特征分析[J].中国临床神经外科杂志,2022,27(07):561.[doi:10.13798/j.issn.1009-153X.2022.07.010]
YANG Yu-hao,LI Zhao-jian,LI Zhuo-qun,et al.Imaging features of intracystic nodules in Rathke cleft cysts: a preliminary study in a single center[J].,2022,27(06):561.[doi:10.13798/j.issn.1009-153X.2022.07.010]
[6]王华,王伟维,王彪.经鼻中隔-蝶窦入路神经内镜手术切除垂体肿瘤[J].中国临床神经外科杂志,2023,28(10):652.[doi:10.13798/j.issn.1009-153X.2023.10.013]
[7]王晓伟,高学军,张波,等.血浆差异表达miRNA预测脑膜瘤术后复发[J].中国临床神经外科杂志,2024,29(07):405.[doi:10.13798/j.issn.1009-153X.2024.07.005]
WANG Xiao-wei,GAO Xue-jun,ZHANG Bo,et al.Pridiction of plasma differentially expressed miRNAs for postoperative recurrence of meningiomas[J].,2024,29(06):405.[doi:10.13798/j.issn.1009-153X.2024.07.005]